Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : The Microcap Kitchen: Stocks 5¢ to $5 -- Ignore unavailable to you. Want to Upgrade?

To: GARY P GROBBEL who wrote (100156)	10/5/2010 11:49:18 AM
From: GARY P GROBBEL	Respond to of 120405

WYY continuing good move...repeated interest in this one since the .80s....every fall back has been met with buying....vol reads have been good....healthy move...gpg

To: GARY P GROBBEL who wrote (100156)	10/5/2010 12:23:00 PM
From: Ted M	Read Replies (1) \| Respond to of 120405

Yes Gary, IVOB is very interesting. But, does it work? The evidence seems to be that it definitely works. See pages 9-12 of the zacks report here: invobioscience.com As with most small cos things have moved slower than originally planned, so the price crumbled. But looks to me like they still have something very viable that could be big in time. As said before though, I am in this for the short term as things seem to be lining up for a move. Will watch of course for long term too as things unfold. You still in VKNG? I think it has much more to go.

To: GARY P GROBBEL who wrote (100156)	10/22/2010 3:24:04 PM
From: Ted M	Read Replies (1) \| Respond to of 120405

Wow, IVOB .06, as hoped to report results on Tuesday: DENVER and BEVERLY, Mass., Oct. 22 /PRNewswire/ -- INVO Bioscience, Inc. (OTC Bulltin Board: IVOB), a medical device company focused on treatment options for patients diagnosed with infertility, today announced that Dr. Elkin Lucena of the Columbian Fertility and Sterility Center (CECOFLES LTDA) will present the results of the first 95 fertility treatment cycles undertaken at the Center utilizing INVO Bioscience's INVOcell technology at the 66th Annual Meeting of the American Society for Reproductive Medicine on October 26, 2010 in Denver, Colorado. The Annual Meeting of the American Society for Reproductive Medicine (ASRM) is one of the premier educational and professional networking conferences in the reproductive field. The theme for this year's event is "Taking Reproductive Medicine to New Heights." The event will feature a wide variety of postgraduate courses, lectures, symposia, roundtables, debates, abstracts, posters and videos focusing attention on the latest scientific developments in the field of reproductive medicine and their translation to clinical medicine. Dr. Claude Ranoux, president of INVO Bioscience, commented, "We look forward with great anticipation to the CECOFLES presentation regarding the use of INVOcell in its initial treatment cycles. We are confident that INVOcell has performed well in these initial applications. Additionally, we are pleased that the study results have been accepted and will be unveiled at a prestigious conference the caliber of the ASRM." About INVO Bioscience INVO Bioscience (IVOB) is a medical device company, headquartered in Beverly, Massachusetts, focused on creating simplified, lower cost treatment options for patients diagnosed with infertility. The company's lead product, the INVOcell, is a novel medical device used in infertility treatment that enables egg fertilization and early embryo development in the woman's vaginal cavity. The company was founded by Claude Ranoux, MD, a noted expert in the field of reproductive health, infertility and embryology. For more information, please visit www.invobioscience.com. Private Securities Litigation Reform Act of 1995